Literature DB >> 22045869

IL-27 inhibits pathophysiological intraocular neovascularization due to laser burn.

Eiichi Hasegawa1, Yuji Oshima, Atsunobu Takeda, Kazuko Saeki, Hiroki Yoshida, Koh-Hei Sonoda, Tatsuro Ishibashi.   

Abstract

AMD is the most common disease leading to acquired blindness in developed countries. CNV is the foremost cause of AMD and is thought to be induced by regional inflammation as a result of age-related conformational changes of the chorioretinal interface. Here, we show that IL-27, a member of the IL-6/IL-12 cytokine family, has an angiostatic effect and regulates the development of laser-induced experimental CNV in mice. In this model, IL-27 expression increased in the damaged choroid and peaked at the 24 h-time-point. IL-27 neutralization, induced by inoculating an antagonistic antibody into the vitreous cavity, enhanced VEGF production and the extent of CNV. By contrast, the administration of rIL-27 reduced VEGF production and the extent of CNV. Mice deficient in the EBI3, which lack IL-27, also showed more CNV than C57BL/6 mice, and this was reduced by IL-27 supplementation. We additionally investigated the effect of IL-27 on the function of macrophages, which play a critical role in CNV. IL-27 did not affect macrophage migration but inhibited its VEGF production. IL-27 therefore appears to regulate CNV and is a promising candidate target for treating sight-threatening diseases caused by ocular neovascularization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22045869     DOI: 10.1189/jlb.1110603

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

Review 1.  Diverse roles of macrophages in intraocular neovascular diseases: a review.

Authors:  Ye-Di Zhou; Shigeo Yoshida; Ying-Qian Peng; Yoshiyuki Kobayashi; Lu-Si Zhang; Luo-Sheng Tang
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

2.  ARMS2 interference leads to decrease of proinflammatory mediators.

Authors:  Fanxing Zeng; Min Zhang; Yiting Xu; Haifeng Xu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-08-20       Impact factor: 3.117

Review 3.  Immunology of age-related macular degeneration.

Authors:  Jayakrishna Ambati; John P Atkinson; Bradley D Gelfand
Journal:  Nat Rev Immunol       Date:  2013-06       Impact factor: 53.106

Review 4.  The role of lymphocytes and phagocytes in age-related macular degeneration (AMD).

Authors:  Verena Behnke; Anne Wolf; Thomas Langmann
Journal:  Cell Mol Life Sci       Date:  2020-01-02       Impact factor: 9.261

5.  Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice.

Authors:  Vincent Lambert; Julie Lecomte; Sylvain Hansen; Silvia Blacher; Maria-Luz Alvarez Gonzalez; Ingrid Struman; Nor Eddine Sounni; Eric Rozet; Pascal de Tullio; Jean Michel Foidart; Jean-Marie Rakic; Agnès Noel
Journal:  Nat Protoc       Date:  2013-10-17       Impact factor: 13.491

6.  Low-dose lipopolysaccharide pretreatment suppresses choroidal neovascularization via IL-10 induction.

Authors:  Nagakazu Matsumura; Motohiro Kamei; Motokazu Tsujikawa; Mihoko Suzuki; Ping Xie; Kohji Nishida
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

7.  Macrophage polarization in experimental and clinical choroidal neovascularization.

Authors:  Yu Yang; Fang Liu; Miao Tang; Miner Yuan; Andina Hu; Zongyi Zhan; Zijing Li; Jiaqing Li; Xiaoyan Ding; Lin Lu
Journal:  Sci Rep       Date:  2016-08-04       Impact factor: 4.379

8.  AAV2/8 Anti-angiogenic Gene Therapy Using Single-Chain Antibodies Inhibits Murine Choroidal Neovascularization.

Authors:  Chris P Hughes; Neil M J O'Flynn; Maureen Gatherer; Michelle E McClements; Jennifer A Scott; Robert E MacLaren; Srinivas Goverdhan; Martin J Glennie; Andrew J Lotery
Journal:  Mol Ther Methods Clin Dev       Date:  2018-11-22       Impact factor: 6.698

9.  Interleukin-27 controls basal pain threshold in physiological and pathological conditions.

Authors:  Tomoko Sasaguri; Toru Taguchi; Yuzo Murata; Kimiko Kobayashi; Sayaka Iizasa; Ei'ichi Iizasa; Makoto Tsuda; Naomi Hirakawa; Hiromitsu Hara; Hiroki Yoshida; Toshiharu Yasaka
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.